news dea-increases-access-to-cannabis-for-research-purposes 
NewsMunchies
MAY 20, 2021
Yet any researcher in the U.S.A. who wishes to legally study the health effects of cannabis have been limited since 1968 to a single legal supplier of the drug. Federal Government – granted a monopoly on the production of medical marijuana for research purposes to the University of Mississippi.
Nature's Way Medicine
FEBRUARY 12, 2021
In this week’s news and updates, we have updates about how Ohio’s medical marijuana market is doing, political lobyists in the cannabis industry, and the Senate’s push for legalization. Federal News. Senate Majority Leader Chuck Schumer Spearheads Effort to Legalize Cannabis. State News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
DECEMBER 27, 2022
A new study has found that psychedelic users have a stronger connection to nature and a greater awareness of their impact on climate change, both qualities associated with environmental consciousness. Let’s dive into what the research says about these promising new findings and how they might advance the field of psychedelic research.
Kind Meds (Cannabis Education Blog)
FEBRUARY 7, 2022
Historical evidence suggests that humans worldwide have been cultivating and consuming cannabis for tens of thousands of years, but cannabis use has skyrocketed in recent years, especially in the US. Our ancestors consumed cannabis flower for recreational, medicinal, and spiritual purposes.
Cannabis Law Report
SEPTEMBER 23, 2019
Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). of the global population uses cannabis annually, making it the most commonly used drug worldwide. of the global population uses cannabis annually, making it the most commonly used drug worldwide. Executive Summary. Relevant AAFP Policy.
Cannabis Law Report
AUGUST 6, 2021
Achieved 23% revenue growth in Q1 2022 versus Q1 2021 driven by strong double-digit growth in both cannabis and other consumer products businesses. Maintained #1 market share 1 in tracked Canadian recreational cannabis market amid a highly competitive landscape. Adjusted EBITDA loss in Q1 2022 was negatively impacted by a $10.1
Cannabis Law Report
JUNE 1, 2021
Achieves 37% revenue growth in FY 2021 with strong double-digit growth across both cannabis and other consumer products businesses. Revenues : Net revenue of $148 million in Q4 2021 was an increase of 38% versus Q4 2020. Canopy Growth Reports Fourth Quarter and Fiscal Year 2021 Financial Results. opportunities in Fiscal 2022.”
Expert insights. Personalized for you.
98 
Let's personalize your content